AM

Andreas Marzinzik

NA Novartis Ag: 8 patents #480 of 5,128Top 10%
NA Novatis Ag: 1 patents #2 of 21Top 10%
Overall (All Time): #530,782 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
12209144 Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders Alec Nathanson Flyer, Andrei Golosov, Philipp Grosche, Ian Lewis, Eugene Yuejin Liu +5 more 2025-01-28
9896444 Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Pascal Furet, Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones, Paul W. Manley +3 more 2018-02-20
9458112 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Pascal Furet, Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones, Paul W. Manley +4 more 2016-10-04
9340537 Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Pascal Furet, Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones, Paul W. Manley +3 more 2016-05-17
9315489 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Pascal Furet, Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones, Paul W. Manley +4 more 2016-04-19
9278981 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Pascal Furet, Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones, Paul W. Manley +4 more 2016-03-08
8829195 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Stephanie Kay Dodd, Pascal Furet, Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones +4 more 2014-09-09
8309596 Kallikrein 7 modulators Stefanie Flohr, Stefan Andreas Randl, Nils Ostermann, Ulrich Hassiepen, Frederic Berst +4 more 2012-11-13
8163773 Organic compounds Werner Breitenstein, Claus Erhardt, Juergen Klaus Maibaum, Nils Ostermann, Juerg Zimmermann +7 more 2012-04-24